Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Cannara Biotech Inc. LOVFF

Set alert

Price alert · LOVFF

All alert types
1.43 USD 0.00 0.00%

At close · Oct 30

1.45 Day range 1.45
1.11 52-week range 1.66
YTD
+12.44%
1 year
+19.00%
Open
1.45
Prev close
1.43
Mkt cap
141.06M
Vol
2.50K
Avg vol
4.59K
EPS
0.08
P/E
17.85
More statistics
Low
1.45
High
1.45

3M chart

Chart tools
Interval
1m5m15m30m

Signals (10)
NameDateAgo
SMA: BearishOct 20, 20261 week ago
MACD: Sell SignalOct 2, 20261 month ago
MACD: Buy SignalSep 22, 20261 month ago
RSI: OverboughtSep 22, 20261 month ago
SMA: BullishSep 14, 20261 month ago
SMA: BearishSep 11, 20261 month ago
MACD: Sell SignalAug 19, 20262 months ago
MACD: Buy SignalAug 10, 20262 months ago
MACD: Sell SignalAug 6, 20262 months ago
MACD: Buy SignalAug 3, 20263 months ago

Financial health

Altman Z-Score

4.07 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

8 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E 12.6×
FY 2018: -76.5×FY 2019: -9.3×FY 2020: -5.8×FY 2021: -82.0×FY 2022: 49.9×FY 2023: 13.0×FY 2024: 10.3×FY 2025: 12.6×
FY 2018 5y median 12.6× FY 2025
P/S 1.5×
FY 2018: 374×FY 2019: 53.4×FY 2020: 27.4×FY 2021: 7.4×FY 2022: 3.2×FY 2023: 1.6×FY 2024: 0.8×FY 2025: 1.5×
FY 2018 5y median 1.6× FY 2025
P/B 1.6×
FY 2018: 11.0×FY 2019: 2.4×FY 2020: 1.8×FY 2021: 2.0×FY 2022: 1.7×FY 2023: 1.1×FY 2024: 0.8×FY 2025: 1.6×
FY 2018 5y median 1.6× FY 2025
P/FCF 11.9×
FY 2018: -10.0×FY 2019: -3.8×FY 2020: -3.8×FY 2021: -3.8×FY 2022: -5.3×FY 2023: -22.7×FY 2024: 20.6×FY 2025: 11.9×
FY 2018 5y median -3.8× FY 2025
EV/EBITDA 6.7×
FY 2018: -96.3×FY 2019: -9.1×FY 2020: -8.2×FY 2021: 45.1×FY 2022: 18.0×FY 2023: 8.3×FY 2024: 7.1×FY 2025: 6.7×
FY 2018 5y median 8.3× FY 2025
EV/Sales 1.8×
FY 2018: 375×FY 2019: 47.1×FY 2020: 29.4×FY 2021: 8.1×FY 2022: 4.2×FY 2023: 2.3×FY 2024: 1.3×FY 2025: 1.8×
FY 2018 5y median 2.3× FY 2025
FCF Yield 8.4%
FY 2018: -10.0%FY 2019: -26.5%FY 2020: -26.0%FY 2021: -26.4%FY 2022: -18.7%FY 2023: -4.4%FY 2024: 4.8%FY 2025: 8.4%
FY 2018 5y median -4.4% FY 2025

Profitability

Gross Margin 44.0%
FY 2018: 36.8%FY 2019: 80.7%FY 2020: 48.0%FY 2021: 60.5%FY 2022: 48.3%FY 2023: 47.6%FY 2024: 36.4%FY 2025: 44.0%
FY 2018 5y median 47.6% FY 2025
Operating Margin 20.7%
FY 2018: -420.0%FY 2019: -487.5%FY 2020: -468.6%FY 2021: 1.5%FY 2022: 13.8%FY 2023: 20.8%FY 2024: 12.3%FY 2025: 20.7%
FY 2018 5y median 13.8% FY 2025
Net Margin 12.2%
FY 2018: -488.4%FY 2019: -587.3%FY 2020: -489.4%FY 2021: -9.0%FY 2022: 6.4%FY 2023: 12.1%FY 2024: 7.9%FY 2025: 12.2%
FY 2018 5y median 7.9% FY 2025
ROE 12.8%
FY 2018: -14.3%FY 2019: -26.1%FY 2020: -32.5%FY 2021: -2.4%FY 2022: 3.5%FY 2023: 8.7%FY 2024: 7.3%FY 2025: 12.8%
FY 2018 5y median 7.3% FY 2025
ROIC 10.9%
FY 2018: -6.5%FY 2019: -16.2%FY 2020: -23.0%FY 2021: 0.3%FY 2022: 4.3%FY 2023: 9.4%FY 2024: 7.3%FY 2025: 10.9%
FY 2018 5y median 7.3% FY 2025
ROA 7.8%
FY 2018: -7.3%FY 2019: -18.1%FY 2020: -22.8%FY 2021: -1.7%FY 2022: 1.8%FY 2023: 4.9%FY 2024: 4.2%FY 2025: 7.8%
FY 2018 5y median 4.2% FY 2025

Growth (YoY)

Revenue 31.3%
FY 2018: 0.0%FY 2019: 384.7%FY 2020: 21.6%FY 2021: 567.2%FY 2022: 110.6%FY 2023: 59.8%FY 2024: 42.8%FY 2025: 31.3%
FY 2018 FY 2025
Operating Income 120.2%
FY 2018: 0.0%FY 2019: -462.6%FY 2020: -16.9%FY 2021: 102.2%FY 2022: 1820.4%FY 2023: 140.6%FY 2024: -15.2%FY 2025: 120.2%
FY 2018 FY 2025
EPS (diluted) 99.1%
FY 2018: 0.0%FY 2019: -457.4%FY 2020: 0.0%FY 2021: 88.2%FY 2022: 231.0%FY 2023: 196.9%FY 2024: -9.6%FY 2025: 99.1%
FY 2018 FY 2025
Free Cash Flow 324.9%
FY 2018: 0.0%FY 2019: -84.1%FY 2020: 39.0%FY 2021: -82.9%FY 2022: 35.0%FY 2023: 81.6%FY 2024: 181.0%FY 2025: 324.9%
FY 2018 FY 2025

Financial Health

Current Ratio 2.4×
FY 2018: 11.6×FY 2019: 5.5×FY 2020: 3.0×FY 2021: 2.8×FY 2022: 3.5×FY 2023: 2.4×FY 2024: 2.5×FY 2025: 2.4×
FY 2018 5y median 2.5× FY 2025
Quick Ratio 1.1×
FY 2018: 11.9×FY 2019: 5.4×FY 2020: 2.4×FY 2021: 1.7×FY 2022: 1.9×FY 2023: 0.8×FY 2024: 1.0×FY 2025: 1.1×
FY 2018 5y median 1.1× FY 2025
Debt / Equity 0.4×
FY 2018: 0.9×FY 2019: 0.3×FY 2020: 0.3×FY 2021: 0.3×FY 2022: 0.7×FY 2023: 0.6×FY 2024: 0.5×FY 2025: 0.4×
FY 2018 5y median 0.5× FY 2025
Net Debt / EBITDA 1.0×
FY 2018: -0.1×FY 2019: 1.2×FY 2020: -0.6×FY 2021: 4.2×FY 2022: 4.3×FY 2023: 2.6×FY 2024: 2.8×FY 2025: 1.0×
FY 2018 5y median 2.8× FY 2025
Interest Coverage 5.9×
FY 2018: -5.7×FY 2019: -6.8×FY 2020: -9.0×FY 2021: 0.2×FY 2022: 1.5×FY 2023: 2.6×FY 2024: 2.4×FY 2025: 5.9×
FY 2018 5y median 2.4× FY 2025

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-08-31